Whilst not expected, shareholders are essentially stumping up to pay for Jennifer Hawkins (just look at the Myer share price during here time as ambassador there, what a terrible appointment), a new vitamins range and other growth opportunities. No wonder the CEO sold down she knew what was coming. In reality, the company has underperformed. One can only hope that the Asian growth story in IF can offset some of the other terrible decisions this company is making.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $151.8M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.0¢ | $91.61K | 522.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 1899644 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 57813 | 3 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| BUB (ASX) Chart |